<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-ijerph-17-01395">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Poespoprodjo</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Fobia</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Kenangalem</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Lampah</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Sugiarto</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Tjitra</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Anstey</surname>
    <given-names>N.M.</given-names>
   </name>
   <name>
    <surname>Price</surname>
    <given-names>R.N.</given-names>
   </name>
  </person-group>
  <article-title>Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes</article-title>
  <source>Malar. J.</source>
  <year>2015</year>
  <volume>14</volume>
  <fpage>272</fpage>
  <pub-id pub-id-type="doi">10.1186/s12936-015-0794-0</pub-id>
  <pub-id pub-id-type="pmid">26169783</pub-id>
 </element-citation>
</ref>
